Below is a list of the experimental treatments targeting beta-amyloid plaques. More information about each potential treatment is available by clicking on the name of the compound. ABvac40 is an ...

Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Dopamine’s involvement in Alzheimer’s treatment stems ... crucial for breaking down beta-amyloid. Neprilysin acts as a natural cleaner, preventing harmful plaques from accumulating in the ...

Recent approvals by the Food and Drug Administration have focused on medications that shrink the sticky brain deposits of a protein called amyloid beta ... if there are few if any treatment options ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Their vigilance and courage contribute to safety, security of nation: PM Modi on BSF Ra ...

Aduhelm was withdrawn from the market. Treatment of Alzheimer’s has been concentrated on targeting beta-amyloid plaques that build up in the brain. Three drugs have been approved in recent years ...

Unlike the previous two approvals, this new therapeutic, named donanemab, targets amyloid beta only at a later stage when it has clumped together to form plaques. It offers similar efficacy to ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...